| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $0.638 (Beat by $0.318) |
| EPS GAAP Actual | $0.638 (Beat by $0.318) |
| Revenue Actual | $0.067886B |
| Revenue Surprise | Beat by $67.886M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.26 |
| EPS GAAP Estimate | $-0.26 |
| Revenue Estimate | $0.0135B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | -0.17 | -2.71 | -0.17 | -0.17 | 1 |
| Dec 2025 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.51 | 0.19 | 0.067886B | 4.98% | 19.51M |
| FQ2 2025 (Jun 2025) | -0.12 | -0.12 | 0.030751B | 57.68% | 17.25M |
| FQ1 2025 (Mar 2025) | -0.41 | -0.41 | 0.015646B | 64.8% | 9.65M |
| FQ4 2024 (Dec 2024) | -0.36 | -0.36 | 0.015585B | 92.89% | 5.89M |
| FQ3 2024 (Sep 2024) | 0.52 | 0.06 | 0.064507B | 16.88% | 6.97M |
| FQ2 2024 (Jun 2024) | -0.21 | 0.04 | 0.013014B | 100% | -3.02M |
| FQ1 2021 (Mar 2021) | 0.39 | 0.39 | 8.5639E-5B | 100% | 0.09M |
| FQ2 2021 (Jun 2021) | -0.19 | -0.19 | 0.00365792B | 100% | 3.66M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.26
Consensus Revenue Estimates
0.0135B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | -0.29 | -- | -0.29 | -0.29 | 1 |
| FQ3 2026 (Sep 2026) | 0.48 | -6.25 | 0.48 | 0.48 | 1 |
| FQ2 2026 (Jun 2026) | -0.03 | -300 | -0.03 | -0.03 | 1 |
| FQ1 2026 (Mar 2026) | -0.26 | -57.69 | -0.26 | -0.26 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.01B | -- | 0.01B | 0.01B | 1 |
| FQ3 2026 (Sep 2026) | 0.08B | 12.29 | 0.08B | 0.08B | 1 |
| FQ2 2026 (Jun 2026) | 0.04B | 12.14 | 0.04B | 0.04B | 1 |
| FQ1 2026 (Mar 2026) | 0.01B | -15.9 | 0.01B | 0.01B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.32 | 0.51 | 0.19 | 37.25% |
| FQ2 2025 (Jun 2025) | 0 | -0.12 | -0.12 | 100% |
| FQ1 2025 (Mar 2025) | 0 | -0.41 | -0.41 | 100% |
| FQ4 2024 (Dec 2024) | 0 | -0.36 | -0.36 | 100% |
| FQ3 2024 (Sep 2024) | 0.46 | 0.52 | 0.06 | 11.54% |
| FQ2 2024 (Jun 2024) | -0.25 | -0.21 | 0.04 | -19.05% |
| FQ1 2021 (Mar 2021) | 0.39 | 0.39 | 100% | |
| FQ2 2021 (Jun 2021) | -0.19 | -0.19 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.05B | $0.07B | $19.51M | 28.73% |
| FQ2 2025 (Jun 2025) | $0.01B | $0.03B | $17.25M | 56.1% |
| FQ1 2025 (Mar 2025) | $0.01B | $0.02B | $9.65M | 61.65% |
| FQ4 2024 (Dec 2024) | $0.01B | $0.02B | $5.89M | 37.76% |
| FQ3 2024 (Sep 2024) | $0.06B | $0.06B | $6.97M | 10.81% |
| FQ2 2024 (Jun 2024) | $0.02B | $0.01B | $-3.02M | -23.17% |
| FQ1 2021 (Mar 2021) | $0B | $0B | $0.09M | 100% |
| FQ2 2021 (Jun 2021) | $0B | $0B | $3.66M | 100% |